What is Swedish Orphan Biovitrum AB Price-to-Operating-Cash-Flow?
As of today (2024-05-06), Swedish Orphan Biovitrum AB's share price is $24.38.
Swedish Orphan Biovitrum AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $1.67. Hence, Swedish Orphan Biovitrum AB's Price-to-Operating-Cash-Flow Ratio for today is 14.63.
The historical rank and industry rank for Swedish Orphan Biovitrum AB's Price-to-Operating-Cash-Flow or its related term are showing as below:
SWTUY'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.31 Med: 27.91 Max: 296.32
Current: 20
During the past 13 years, Swedish Orphan Biovitrum AB's highest Price-to-Operating-Cash-Flow Ratio was 296.32. The lowest was 8.31. And the median was 27.91.
Swedish Orphan Biovitrum AB's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was $0.80.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $1.67.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Swedish Orphan Biovitrum AB was -11.10% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -4.60% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 11.70% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 43.10% per year.
During the past 13 years, Swedish Orphan Biovitrum AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 113.20% per year. The lowest was -91.80% per year. And the median was 24.75% per year.
Swedish Orphan Biovitrum AB Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Swedish Orphan Biovitrum AB's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Swedish Orphan Biovitrum AB Price-to-Operating-Cash-Flow Chart
|
Swedish Orphan Biovitrum AB Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
12.52 |
10.04 |
10.04 |
14.07 |
19.47 |
|
Swedish Orphan Biovitrum AB Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
14.64 |
12.60 |
13.20 |
19.47 |
19.08 |
Competitive Comparison of Swedish Orphan Biovitrum AB's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Swedish Orphan Biovitrum AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Swedish Orphan Biovitrum AB's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Swedish Orphan Biovitrum AB's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Swedish Orphan Biovitrum AB's Price-to-Operating-Cash-Flow falls into.
Swedish Orphan Biovitrum AB Price-to-Operating-Cash-Flow Calculation
Swedish Orphan Biovitrum AB's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 24.38 | / | 1.667 |
| = | 14.63 |
Swedish Orphan Biovitrum AB's Share Price of today is $24.38.
Swedish Orphan Biovitrum AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.67.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Swedish Orphan Biovitrum AB (Swedish Orphan Biovitrum AB) Business Description
Traded in Other Exchanges
Address
Tomtebodavagen 23 A, Solna, Stockholm, SWE, SE-112 76
Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hematology and immunology. Biovitrum started with experience in studying recombinant proteins such as hemophilia factors, and partnered with Syntonix (now part of Sanofi) on long-acting hemophilia factor replacement programs in 2006. Biovitrum acquired Orfadin and a partnered product business with the acquisition of Swedish Orphan. Sobi launched hemophilia products Alprolix and Eloctate in Europe in 2016. Sobi has since been building its immunology pipeline (rare disease drug Gamifant, U.S. rights to RSV antibodies Synagis and Beyfortus, gout drug SEL-212, complement drug Aspaveli) and hematology pipeline outside of hemophilia (thrombocytopenia drug Doptelet, blood cancer drug Zynlonta, myelofibrosis drug Vonjo).
Swedish Orphan Biovitrum AB (Swedish Orphan Biovitrum AB) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SWTUY has been successfully added to your